Cognito Therapeutics Stock / BioTech & PharmaFounded: 2016

Cognito Therapeutics is a developer of a pipeline of disease-modifying digital therapeutics intended to cure neurodegenerative disorders. The company's therapies aim to use induced brain wave oscillations to treat Alzheimer's by reactivating the immune system in the brain, enabling patients to reduce typical hallmarks of the disease like amyloid plaques and tau tangles.

Register To Buy and Sell Shares

For more details on financing and valuation for Cognito Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Cognito Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Cognito Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Cognito Therapeutics investors also invested in these private companies

FoundersX Ventures
Starbloom Capital
Alzheimers Drug Discovery Foundation
Wilson Sonsini Goodrich & Rosati


Management Team

Brent Vaughan
Chief Executive Officer
Zach Malchano
President & Chief Research & Development Officer
Mihaly Hajos
Chief Scientific Officer
Li-Huei Tsai Ph.D
Ralph Kern MD
Chief Medical Officer
Jonathan Lieber
Chief Financial Officer
Everett Crosland
Chief Commercial Officer
Edward Boyden Ph.D

Board Members

Stephen Bruso
Morningside Group

Frequently Asked Questions About Cognito Therapeutics’ Stock

Can you buy Cognito Therapeutics’ stock?
Cognito Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Cognito Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Cognito Therapeutics’ stock?
Yes, you can sell stock of a private company like Cognito Therapeutics. Forge can help you sell your Cognito Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Cognito Therapeutics’ stock price?
Cognito Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Cognito Therapeutics’ private market stock price with Forge Data.
What is Cognito Therapeutics’ stock ticker symbol?
Cognito Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: May 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.